Study Safety & Oversight
We prioritize the highest standards of safety and scientific integrity in every clinical trial we manage.
How safe are clinical studies?
Clinical studies are conducted under strict oversight to safeguard participants. Every project must first be reviewed and approved by an Institutional Review Board (IRB)—a panel of medical experts, scientists, and community representatives who determine whether the potential benefits justify any risks. The IRB continues to supervise the trial throughout its course.
What is the role of an IRB?
The IRB is a critical independent committee that evaluates the scientific merit and ethical soundness of a research protocol. It ensures that all study-related risks are minimized and that the rights and welfare of participants are protected at every stage of the trial.
What is a Data Safety Monitoring Board (DSMB)?
Many neuroscience-focused studies employ a DSMB—an independent committee that periodically reviews trial data to ensure participant well-being and scientific integrity. This committee can recommend stopping a study early if safety concerns arise.
How are risks explained to participants?
Before enrollment, the research team will carefully explain all known and possible risks. Participants are monitored closely and supported throughout the trial, ensuring that every volunteer is fully informed and comfortable with their participation.
Is health insurance required?
No. Health insurance is not necessary to participate. In most cases, the trial sponsor—often a pharmaceutical or biotechnology company—covers the cost of the investigational therapy, study-related assessments, and medical monitoring.
What is the informed consent process?
Informed consent is a vital step designed to protect participants. During this process, the research team explains the purpose, timeline, procedures, and all potential risks. You will receive a copy of the consent document for personal reference.
Risks & Drawbacks
Time Involvement: Participation may require more frequent appointments, phone check-ins, or follow-up visits compared to standard clinical care.
Extra Testing: You may undergo additional evaluations such as imaging scans, lab draws, or neurological assessments beyond routine medical practice.
Treatment Reactions: Side effects may occur, ranging from mild discomfort to more significant complications, depending on the investigational therapy.
Outcome Uncertainty: The effectiveness of an investigational therapy may not be established until the study concludes, and results are subject to scientific review.
Participation Costs
Health insurance is not required to participate in our clinical trials. In most cases, the trial sponsor—often a pharmaceutical or biotechnology company—covers the cost of the investigational therapy, study-related assessments, and medical monitoring. This ensures that participation remains open and equitable for all volunteers.
The Informed Consent Process
1. Information Disclosure
- Clear explanation of the study's purpose and objectives
- Details regarding the expected timeline and duration
- Comprehensive overview of all procedures and evaluations
- Identification of potential risks, benefits, and alternatives
2. Data Safeguarding
- How personal health information will be protected
- Clarification of data collection and storage methods
- Confirmation of privacy rights and data access
3. Voluntary Participation
- Signing a detailed consent document summarizing the discussion
- Receiving a copy for personal reference
- Explicit right to withdraw at any time without impact on care